title: [ACTIVATION OF PROTEIN C IN THE IN VITRO THROMBOLYSIS].
abstract: Physiological conditions of formation and subsequent lysis of thrombus were reconstituted in vitro in our research. Thrombus formation was initiated either by addition of exogenous thrombin or by contact of blood with anionic surface, which stimulates spontaneous coagulation of blood. Tissue plasminogen activator and/or protein C were previously added in the blood sample. The time of the beginning and total degradation of formed thrombi as well as the level of PC in lysates was controlled then. Only an addition of protein C alone or in combination with tissue plasminogen activator led to the most effective lysis of thrombi: their residual weight was 18% and 5% comparing to control. Addition of exogenous tissue plasminogen activator alone or in combination with protein C caused a 83% and 74% decrease of PC level in lysates of spontaneously formed thrombi, and 72% and 56% decrease for thrombi formed by thrombin, respectively. Without an addition of tissue plasminogen activator protein C level in lysates of thrombi formed by thrombin was 54% down on spontaneously formed thrombi. Thus, changes of PC concentration in isolated volume of clot seem to be controlled by thrombin at the stage of thrombus formation and by fibrinolytic system at the stage of fibrinolysis. Concentration of PC in lysates from clots formed by exogenous thrombin was decreasing over the next 10 hours of thrombolysis, which can also be the evidence of the interaction between the fibrinolytic and PC activation systems. A hypothesis is. formulated about an existence of endothelium-independent mechanism of PC activation in blood plasma with blood cells participation, which effectiveness increases in the process of thrombolysis.
authors.forename: L I
authors.initials: LI
authors.lastname: Patalakh
authors.forename: S A
authors.initials: SA
authors.lastname: Talanov
authors.forename: O V
authors.initials: OV
authors.lastname: Revka
authors.forename: T F
authors.initials: TF
authors.lastname: Drobotko
mesh_terms: D001773:Blood Cells / Q000187:drug effects*; D046508:Culture Techniques; D004789:Enzyme Activation / Q000187:drug effects; D005342:Fibrinolysis / Q000502:physiology*; D006801:Humans; D010949:Plasma / Q000187:drug effects*; D011486:Protein C / Q000819:agonists* / Q000378:metabolism / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology*; D013927:Thrombosis / Q000378:metabolism; D010959:Tissue Plasminogen Activator / Q000494:pharmacology
chemical_list: D011486:Protein C; D013917:Thrombin; D010959:Tissue Plasminogen Activator